# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-21-051864
Filing Date
2021-04-19
Accepted
2021-04-19 14:09:30
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | tm212636d3_defa14a.htm | DEFA14A | 22764
2 | GRAPHIC | tm212636d3_defa14aimg001.jpg | GRAPHIC | 560330
3 | GRAPHIC | tm212636d3_defa14aimg002.jpg | GRAPHIC | 428382
| Complete submission text file | 0001104659-21-051864.txt |  | 1385750

Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39202 | Film No.: 21834027
SIC: 2834 Pharmaceutical Preparations